Harry Z. Rosengart

Harry Z. Rosengart

Founder at Sunpharm Corp.

Finance
Health Services
Health Technology

Profile

Mr. Rosengart is President and CEO of HK & Associates, an investment and consulting firm, specializing in financial and strategic advice to small and medium-sized companies with an emphasis on life sciences.
He is also the founder of LigoTech, Inc., a privately held DNA/RNA and macromolecule bioseparations company employing 14 individuals.
For three years, he served as Chairman of its Board of Directors, President and CEO and is currently a Member of the Board of Directors.
He raised $5 million in two equity rounds of capital.
During his tenure, he consummated several licensing transactions, acquired Affinity Biotechnology and successfully integrated the acquisition into LigoTech and launched a number of products.
Mr. Rosengart is also co-founder of SunPharm Corporation, an anti-cancer drug development-stage company.
Mr. Rosenhart is active in a number of civic and professional organizations and holds a B.S.
in Chemical Engineering and an MBA from Rutgers University.

Harry Z. Rosengart active positions

CompaniesPositionStart
Founder 2009-09-09
Corporate Officer/Principal 2009-09-09
All active positions of Harry Z. Rosengart

Former positions of Harry Z. Rosengart

CompaniesPositionEnd
DYADIC INTERNATIONAL, INC. Chairman 2008-06-17
Analyst-Equity -
See the detail of Harry Z. Rosengart's experience

Training of Harry Z. Rosengart

Rutgers State University of New Jersey Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harry Z. Rosengart's experience

Connections

6

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
DYADIC INTERNATIONAL, INC.

Health Services

Private companies3

Finance

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Harry Z. Rosengart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW